Connect with us

Health and Wellness

Are private hospitals really in trouble? Is the solution to increase public funding?

Published

on

AND battle between private hospitals and private health insurers plays out in society.

The bottom line is how much insurers pay hospitals for his or her services and whether that’s enough for private hospitals to remain profitable.

Concerns about the viability of the private health care system caught the attention of the federal government, which launched the program review to private hospitals which have not yet been made public.

But are private hospitals really in trouble? And if that’s the case, will more public funding be the solution?

Private hospitals vs private health insurers

Many private hospital operators have reported significant pressure since the start of the Covid-19 pandemic, including: staff shortages.

Inflationary pressures have increased the costs of supplies and equipment, raising costs providing hospital care.

Now private hospitals have publicized their difficult contract negotiations with private insurers in an attempt to gain support and help in their case.

Healthscope, which operates 38 for-profit private hospitals in Australia dangerous end contracts with private health insurers.

St Vincent’s, which operates ten private not-for-profit hospitals, announced this might terminate the contract with Nib (certainly one of Australia’s largest for-profit health insurers), but then reached an agreement.

UnitingCare Queensland, which runs 4 private hospitals, announced it might terminate its contract with the Australian Health Service Alliance, which represents greater than 20 small and medium-sized, not-for-profit private health insurers. Since then, each side have been doing in order well I kissed and made up.

Why should we care?

There are three explanation why the profitability of the private health sector affects all of us, whether we’ve got private medical health insurance or use private hospitals.

1. Taxpayers subsidize private health care

Australian taxpayers contributed to private medical health insurance premiums, including: AUD 6.3 billion
(in premium rebates) in 2021-22. Most of them go to private hospitals. Medicare also subsidized fees for medical services provided to private patients in private and public hospitals in the amount of approx $3.81 billion in 2023–24.

But when the going gets tough, the private healthcare sector (each hospitals and health insurers) turns to the government for more information materials.

That’s why we must always worry about value what we’re currently getting from our public investment in the private healthcare system and whether further public investment is justified.

2. The closure of private hospitals may affect public hospitals

Calls for greater government support for private healthcare have long argued that a bigger private hospital sector would help reduce pressure on the public system.

Indeed, this was the justification for the series incentives introduced in the late Nineties to support private medical health insurance in Australia.

However, the extent of this phenomenon is hotly debated. Last evidence shows that higher levels of private medical health insurance lead to only a really small reduction in waiting times in public hospitals.

While it’s possible that the closure of a couple of private hospitals could prompt some patients to seek care in public hospitals, the change might not be that big and won’t increase wait times much.

3. Fewer private beds, but is that a nasty thing?

If unprofitable private hospitals are closed or merged, we expect the total variety of beds in private hospitals to decrease.

Fewer beds in private hospitals doesn’t necessarily mean bad news. In particular, mergers of small private day hospitals could increase their efficiency and reduce costs, which in turn would lower medical health insurance premiums.

We might have fewer private beds. This is due to policies attempting to move health care from hospitals to the community or the use of hospital-at-home programs (in which patients receive hospital-type care at home with the support of visiting medical staff and/or telehealth). ). Private health insurers support each.

The closure of several small private hospitals will mean the market adapts to the lower demand for hospital care. Some of the closures were in maternity wards, but with falling birth ratethis also looks like an appropriate market correction.

Falling birth rates mean less need for maternity wards.
Christinarosepix/Shutterstock

What will we know?

There is all objective data on what is going on in the private hospital sector scarce. This is principally because the Australian Bureau of Statistics suspended the mandatory examination all private hospitals. The most up-to-date data we’ve got is from 2016–2017.

Health insurers are the largest payer of private hospitals and subsequently have considerable bargaining power. In 2016–17, almost 80% Private hospitals’ revenues got here from private health insurers. Health insurers are also increasingly becoming “active” purchasers of health care – they don’t just passively pay insurance claims, but want to strike a great cope with private hospitals in order that their members can keep premiums (and costs) low and profits high.

Hospital reports close ignore hospitals which can be open at the same time. However, as of 2016–2017, there isn’t any publicly available data on the total variety of private hospitals in Australia or changes over time.

The latest data we’re talking about half All hospitals in Australia are private hospitals, including: 62% are for-profit and the rest are run by non-profit organizations (reminiscent of St Vincent’s).

The predominant for-profit providers are Ramsay Health Care and Healthscope. They each operate overseas and have been there troubles before the Covid pandemic.

Fast forward to 2024 and up to date contract negotiation problems suggest that the financial health of private for-profit hospitals may not have improved. This may subsequently reflect a long-term problem with the sustainability of the private hospital sector.

What are the options?

The private healthcare system already receives large public subsidies. So the crux of the current debate is whether or not the government should intervene to support the private sector. Here are some options:

  • do nothing and let it play out Closing and merging private hospitals could also be a great solution if smaller hospitals and wards are not any longer needed and patients produce other alternatives

  • introduce more regulations Negotiations between small private hospital groups and really large, dominant private health insurers might not be effective. If insurers have significant market power, they’ll force small private hospital groups into submission. Some private hospital groups could also be negotiating with many various health insurers at the same time, which may be expensive. Regulating exactly how these negotiations are conducted could increase the efficiency of the process and create a more level playing field

  • change the way private hospitals are paid Public hospitals receive essentially the same national price for every procedure they perform. This provides incentives for efficiency because the price is fixed, so if costs are lower than price, they’ll generate a surplus. Private hospitals may be financed in this fashion, which could eliminate much of the cost of contract negotiations with private hospitals. Instead, private hospitals could deal with other issues, reminiscent of the number and quality of procedures and the provision of high-quality health care.

Patients waiting in a modern, spacious waiting room of a hospital or clinic
How can we help private hospitals turn into more efficient? Price regulation and contract negotiations are the starting.
Kitreel/Shutterstock

What’s next?

A revisit of price regulation and contract negotiations between private hospitals and private health insurers could potentially help the private hospital sector turn into more efficient.

Private health insurers are rightly trying to encourage such efficiency, but the tools at their disposal to achieve this through contract negotiations are quite blunt.

While waiting for the results of the review of the private hospital sector, the most significant thing is value for money for taxpayers. We all subsidize the private hospital sector.

This article was originally published on : theconversation.com
Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health and Wellness

Jury awarded $310 million to parents of teenager who died after falling on a ride at Florida amusement park – Essence

Published

on

By

Sun Sentinel/Getty Images

The family of Tire Sampson, the 14-yr-old who tragically died on an amusement park ride in Orlando, Florida, in 2022, has been awarded $310 million in a civil lawsuit.

Tire, who was visiting ICON Park along with his family on March 24, 2022, fell from the FreeFall drop tower. Although he was taken to a nearby hospital, he didn’t survive his injuries.

Now, greater than two years later, a jury has held the vehicle manufacturer, Austria-based Funtime Handels, responsible for the accident and awarded the Tire family $310 million. According to reports from local news stations WFTV AND KSDKthe jury reached its verdict after about an hour of deliberation.

Tyre’s parents will each receive $155 million, according to attorney spokesman Michael Haggard.

Attorneys Ben Crump and Natalie Jackson, who represented Tyre’s family, shared their thoughts on this landmark decision via X (formerly Twitter). “This ruling is a step forward in holding corporations accountable for the safety of their products,” they said in a statement.

Lawyers stressed that Tyre’s death was attributable to “gross negligence and a failure to put safety before profits.” They added that the ride’s manufacturer had “neglected its duty to protect passengers” and that the substantial award ensured it could “face the consequences of its decisions.”

Crump and Jackson said they hope the result will encourage change throughout the theme park industry. “We hope this will spur the entire industry to enforce more stringent safety measures,” they said. “Tire heritage will provide a safer future for drivers around the world.”

An investigation previously found that Tyre’s harness was locked through the descent, but he dislodged from his seat through the 430-foot fall when the magnets engaged. Tire’s death was ruled the result of “multiple injuries and trauma.”

ICON Park said at the time that it could “fully cooperate” with the authorities.

This article was originally published on : www.essence.com
Continue Reading

Health and Wellness

Tireless HIV/AIDS advocate A. Cornelius Baker dies

Published

on

By

HIV/AIDS Advocate, A. Cornelius Baker


A. Cornelius Baker, a tireless advocate of HIV and AIDS testing, research and vaccination, died Nov. 8 at his home in Washington, D.C., of hypertensive, atherosclerotic heart problems, in response to his partner, Gregory Nevins.

As previously reported, Baker was an early supporter for people living with HIV and AIDS within the Nineteen Eighties, when misinformation and fear-mongering in regards to the disease were rampant.

According to Douglas M. Brooks, director of the Office of National AIDS Policy under President Obama, it was Baker’s Christian faith that guided him toward compassion for others.

“He was very kind, very warm and inclusive – his circles, both professional and personal, were the most diverse I have ever seen, and he was guided by his Christian values,” Brooks told the outlet. “His ferocity was on display when people were marginalized, rejected or forgotten.”

In 1995, when he was executive director of the National AIDS Association, Baker pushed for June 27 to be designated National HIV Testing Day.

In 2012, he later wrote on the web site of the Global Health Advisor for which he was a technical advisor that: “These efforts were intended to help reduce the stigma associated with HIV testing and normalize it as part of regular screening.”

https://twitter.com/NBJContheMove/status/1856725113967632663?s=19

Baker also feared that men like himself, black gay men, and other men from marginalized communities were disproportionately affected by HIV and AIDS.

Baker pressured the Clinton administration to incorporate black and Latino people in clinical drug trials, and in 1994 he pointedly told the Clinton administration that he was bored with hearing guarantees but seeing no motion.

According to Lambda Legal CEO Kevin Jennings, yes that daring attitude that defines Baker’s legacy in the world of ​​HIV/AIDS promotion.

“Cornelius was a legendary leader in the fight for equality for LGBTQ+ people and all people living with HIV,” Jennings said in a press release. “In the more than twenty years that I knew him, I was continually impressed not only by how effective he was as a leader, but also by how he managed to strike the balance between being fierce and kind at the same time. His loss is devastating.”

Jennings continued: “Cornelius’ leadership can’t be overstated. For many years, he was one in all the nation’s leading HIV/AIDS warriors, working locally, nationally and internationally. No matter where he went, he proudly supported the HIV/AIDS community from the Nineteen Eighties until his death, serving in various positions including the Department of Health and Human Services, the National Association of Persons with Disabilities AIDS, and the Whitman-Walker Clinic . Jennings explained.

Jennings concluded: “His career also included several honors, including being the first recipient of the American Foundation for AIDS Research Foundation’s organization-building Courage Award. Our communities have lost a pillar in Cornelius, and as we mourn his death, we will be forever grateful for his decades of service to the community.”

Kaye Hayes, deputy assistant secretary for communicable diseases and director of the Office of Infectious Diseases and HIV/AIDS Policy, in her comment about his legacy, she called Baker “the North Star.”.

“It is difficult to overstate the impact his loss had on public health, the HIV/AIDS community or the place he held in my heart personally,” Hayes told Hiv.gov. “He was pushing us, charging us, pulling us, pushing us. With his unwavering commitment to the HIV movement, he represented the north star, constructing coalitions across sectors and dealing with leaders across the political spectrum to deal with health disparities and advocate for access to HIV treatment and look after all. He said, “The work isn’t done, the charge is still there, move on – you know what you have to do.” It’s in my ear and in my heart in the case of this job.

Hayes added: “His death is a significant loss to the public health community and to the many others who benefited from Cornelius’ vigilance. His legacy will continue to inspire and motivate us all.”

Baker is survived by his mother, Shirley Baker; his partner Nevins, who can be senior counsel at Lambda Legal; his sisters Chandrika Baker, Nadine Wallace and Yavodka Bishop; in addition to his two brothers, Kareem and Roosevelt Dowdell; along with the larger HIV/AIDS advocacy community.


This article was originally published on : www.blackenterprise.com
Continue Reading

Health and Wellness

Bovaer is added to cow feed to reduce methane emissions. Does it pass into milk and meat? And is it harmful to humans?

Published

on

By

There are growing concerns in regards to the use of feed supplements, Bowar 10to reduce methane production in cows.

Bovaer 10 consists of silicon dioxide (mainly sand), propylene glycol (food stabilizer approved by Food Safety Australia New Zealand) and lively substance 3-nitrooxypropanol (3-NOP).

There has been an enormous amount of misinformation in regards to the safety of 3-NOP, with some milk from herds fed this additive being labeled “Frankenmilk”. Others feared it could get to humans through beef.

The most significant thing is that 3-NOP is secure. Let’s clear up some major misconceptions.

Why do we want to limit methane production?

In our attempts to limit global warming, we’ve placed the best emphasis on CO₂ because the major man-made greenhouse gas. But methane is also a greenhouse gas, and although we produce less of it, it is: a much stronger greenhouse gas than CO₂.

Agriculture is the largest a man-made source of methane. As cattle herds expand to meet our growing demand for meat and milk, reducing methane production from cows is a vital way to reduce greenhouse gas emissions.

There are several ways to do that. Stopping bacteria within the stomachs of cows that produce methane one approach is to produce methane.

The methane produced by cows and sheep doesn’t come from the animals themselves, but from the microbes living of their digestive systems. 3-NO stop the enzymes that perform the last step of methane synthesis in these microorganisms.

3-NOP is not the one compound tested as a feed additive. Australian product based on seaweed, Rumin8for instance, it is also in development. Saponins, soap-like chemicals present in plants, and essential oils as well has been examined.

However, 3-NOP is currently one of the popular effective treatments.

Nitrooxypropanol structure: red balls are oxygen, gray carbon, blue nitrogen and white hydrogen.
PubChem

But is not it poison?

There are concerns on social media that Bovaer is “poisoning our food.”

But, as we are saying in toxicology, it’s the dose that makes the poison. For example, arsenic is deadly 2–20 milligrams per kilogram of body weight.

In contrast, 3-NOP was not lethal on the doses utilized in safety studies, up to 600 mg 3-NOP per kg body weight. At a dose of 100 mg per kg body weight in rats, it didn’t cause any adversarial effects.

What about reproductive issues?

The effect of 3-NOP on the reproductive organs has generated numerous commentary.

Studies in rats and cows showed that doses of 300–500 mg per kg body weight caused: contraction of the ovaries and testicles.

In comparison, to achieve the identical exposure in humans, a 70 kg human would want to eat 21–35 grams (about 2 tablespoons) of pure 3-NOP every day for a lot of weeks to see this effect.

No human will likely be exposed to this amount because 3-NOP doesn’t pass into milk – is fully metabolized within the cow’s intestines.

No cow will likely be exposed to these levels either.

The cow licks itself
Cows will not be exposed to levels tested on animals in laboratory studies.
Ground photo/Shutterstock

What about cancer?

3-NOP is not genotoxic or mutagenicwhich implies it cannot damage DNA. Thus, the results of 3-NOP are dose-limited, meaning that small doses will not be harmful, while very high doses are (unlike radiation where there is no secure dose).

Scientists found that at a dose of 300 mg per kilogram of body weight benign tumors of the small intestine of female ratsbut not male rats, after 2 years of every day consumption. At a dose of 100 mg 3-NOP per kg body weight, no tumors were observed.

Cows eat lower than 2 grams of Bovaer 10 per day (of which only 10% or 0.2 grams is 3-NOP). This is about 1,000 times lower than the appropriate every day intake 1 mg 3-NOP per kg body weight per day for a cow weighing 450 kg.

This level of consumption will likely be not the result in cancer or any of them other adversarial effects.

So how much are people exposed to?

Milk and meat consumers will likely be exposed to zero 3-NOP. 3-NOP doesn’t penetrate milk and meat: is completely metabolized within the cow’s intestines.

Farmers could also be exposed to small amounts of the feed additive, and industrial employees producing 3-NOP will potentially be exposed to larger amounts. Farmers and industrial employees already wear personal protective equipment to reduce exposure to other agricultural chemicals – and it is advisable to do that with Bovear 10 as well.

Milk
3-NOP doesn’t penetrate milk and meat.
Shutterstock

How widely has it been tested?

3-NOP has been in development for 15 years and has been subject to multiple reviews by European Food Safety Authority, UK Food Safety Authority AND others.

It has been extensively tested over months of exposure to cattle and has produced no unintended effects. Some studies actually say so improves the standard of milk and meat.

Bovaer was approved for use in dairy cattle by the European Union from 2022 and Japan in 2024. It is also utilized in many other countries, including: in beef products, amongst others Australia.

A really small amount of 3-NOP enters the environment (lower than 0.2% of the dose taken), no accumulates and is easily decomposed subsequently, it doesn’t pose a threat to the environment.

Since humans will not be exposed to 3-NOP through milk and meat, long-term exposure is not an issue.

What does Bill Gates have to do with this?

Bill Gates has invested in a distinct feed processing method for methane, Australian seaweed-based Rumin8. But he has nothing to do with Bovaer 10.

The Bill & Melinda Gates Foundation awarded research grants to the corporate producing 3-NOP for malaria control researchnot for 3-NOP.

The bottom line is that adding 3-NOP to animal feed doesn’t pose any risk to consumers, animals or the environment.

This article was originally published on : theconversation.com
Continue Reading
Advertisement

OUR NEWSLETTER

Subscribe Us To Receive Our Latest News Directly In Your Inbox!

We don’t spam! Read our privacy policy for more info.

Trending